Dr. Lugogo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
380 Parkland Plaza
Ann Arbor, MI 48103Phone+1 734-998-7380
Clinical Expertise
- Refractory asthma
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2001 - 2004
Virginia Commonwealth University School of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2017 - 2027
NC State Medical License 2001 - 2018- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellows Teaching Award Pulmonary Division, University of Michigan, 2019
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
- PackHealth: Asthma Engagement Tool Start of enrollment: 2015 Aug 01
- Expansion of the COPD At-risk Module in 4 States BRFSS Telephone Health Surveys Start of enrollment: 2015 Jan 01
Publications & Presentations
PubMed
- 94 citationsS-Nitrosoglutathione Reductase: An Important Regulator in Human AsthmaLoretta G. Que, Zhonghui Yang, Jonathan S. Stamler, Njira L Lugogo, Monica Kraft
American Journal of Respiratory and Critical Care Medicine. 2009-08-01 - 36 citationsBenralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis.Giorgio Walter Canonica, Tim Harrison, Pascal Chanez, Francesco Menzella, Renaud Louis
Allergy. 2021-05-12 - 87 citationsOnset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asth...Tim W Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis
The Lancet. Respiratory Medicine. 2021-03-01
Press Mentions
NAVIGATOR Steers Uncontrolled Asthma Toward Calmer SeasMay 18th, 2022- NAVIGATOR: Nearly Half of Patients with Severe, Uncontrolled Asthma Improved with TezepelumabMay 17th, 2022
- When All Else Failed, Biologics Helped Her Breathe AgainFebruary 28th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
